Study protocol for the Functional Communication Checklist for people living with primary progressive aphasia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 19 03 2024
accepted: 27 08 2024
medline: 12 9 2024
pubmed: 12 9 2024
entrez: 12 9 2024
Statut: epublish

Résumé

This study protocol describes the development of the first instrument of functional communication for people living with primary progressive aphasia (PPA), with future applications to other progressive conditions, with expert validation, item-level reliability analyses, input from partners in research, and outcomes. Progressive conditions like PPA require monitoring, and as such, re-assessment. Re-assessment poses the high risk of being burdensome, destructive, and of little use to the patient. As such, there is a significant need to establish a validated and reliable measure that (1) poses minimal patient burden and (2) captures communication ability in a strengths-based manner for both clinical and research purposes. A strengths-based approach to assessment is widely recognized as the optimal way to promote patient autonomy, minimize harm, and implement functional treatment protocols and strategies. To date, there are no strengths-based assessment tools that were developed for people living with PPA nor ways to efficiently document functional communication performance. This study protocol outlines our work to address this gap in clinical practice and research.

Identifiants

pubmed: 39264982
doi: 10.1371/journal.pone.0301652
pii: PONE-D-24-11115
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0301652

Informations de copyright

Copyright: © 2024 Gallée et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist. The experimental approach described in this manuscript is supported by a 2024-2025 University of Washington Alzheimer’s Disease Research Center Development Project Award (JG). This work was also supported by the National Institute on Aging (U24 AG074855: JG & PKC; P30 AG066509: KDR).

Auteurs

Jeanne Gallée (J)

Department of Medicine, University of Washington, Seattle, WA, United States of America.

Jade Cartwright (J)

School of Health Sciences, University of Tasmania, Launceston, Australia.

Maya L Henry (ML)

Department of Speech, Language, and Hearing Sciences, University of Texas-Austin, Austin, TX, United States of America.

Aimee Mooney (A)

Department of Neurology, Oregon Health & Science University, Portland, OR, United States of America.

Brielle C Stark (BC)

Department of Speech, Language, and Hearing Sciences, Indiana University, Bloomington, IN, United States of America.

Anna Volkmer (A)

Division of Psychology and Language Sciences, University College London, London, United Kingdom.

Connie Nakano (C)

Department of Medicine, University of Washington, Seattle, WA, United States of America.

Rob J Fredericksen (RJ)

Department of Allergy and Infectious Diseases, University of Washington, Seattle, WA, United States of America.

Kimiko Domoto-Reilly (K)

Department of Neurology, University of Washington, Seattle, WA, United States of America.

Paul K Crane (PK)

Department of Medicine, University of Washington, Seattle, WA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH